Huifeng Bio-Pharmaceutical Technology Inc. (HFGB.OB) is “One to Watch”
Huifeng Bio-Pharmaceutical Technology Inc., located in Xi'an, People's Republic of China, is focused on developing, producing and selling plant extracts,…
Blog
XenaCare Holdings, Inc. (XCHO.OB) Partners With Renaissance Publishing
XenaCare Holdings, Inc., a Florida based healthcare products company, today announced signing of an agreement with Renaissance Publishing LLC, for…
LeCroy Corp. (LCRY) Reports Preliminary First Quarter Results
LeCroy Corp. is a worldwide leader in serial data test solutions and oscilloscopes. The company offers high-performance oscilloscopes, serial data…
Clear Skies Solar, Inc. (CSKH.OB) Receives High Praise for XTRAX® Technology
Clear Skies Solar, Inc. may have blue skies in their future as indicated by today's announcement about the success of…
Golden Star Resources (GSS) is “One to Watch”
Golden Star Resources is a mid-tier, unhedged gold mining company which over its 25-year history has produced in excess of…
CEL-SCI Corp. (CVM) is “One to Watch”
CEL-SCI Corp. is a biopharmaceutical company dedicated to improving the treatment of cancer and other infectious diseases by unleashing the…
Security Federal Corp. (SFDL.OB) to Participate in United States Department of the Treasury’s Community Development Capital Initiative
Security Federal Corporation, the holding company for Security Federal Bank, announced yesterday that they were approved to participate in United…
Derycz Scientific, Inc. (DYSC.OB) Reports 70% Revenue Increase for Fiscal Year 2010
Derycz Scientific, Inc., a company that deals in getting information and content from publishers to consumers, reported financial and operating…
China Pharmaceuticals, Inc. (CFMID.OB) Issues Reverse Stock Split to Gain Footing for Senior Exchange Listing
China Pharmaceuticals Inc., a leading manufacturer and distributor of prescription and over-the-counter pharmaceuticals in China, today announced it has effected…
Shengtai Pharmaceutical, Inc. (SGTI.OB) Reports Fiscal 2010 Financial Results, Returns to Profit
Shengtai Pharmaceutical Inc. operates through its wholly owned subsidiary, Shengtai Holding Inc., to manufacture and distribute glucose and starch as…